Fluid Resuscitation Optimization in Surgical Trauma Patients (FROST)
Status: | Recruiting |
---|---|
Conditions: | Hospital, Hospital |
Therapuetic Areas: | Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | December 2015 |
End Date: | December 2019 |
Contact: | Audis Bethea, PharmD, BCPS |
Email: | audis.bethea@camc.org |
Phone: | 304-388-3653 |
The aim of this study is to determine if the incidence of post-operative complications can
be decreased by the implementation of intra-operative, minimally invasive hemodynamic
monitoring (MIHM) via FloTrac™ and EV1000™ in trauma patients.
be decreased by the implementation of intra-operative, minimally invasive hemodynamic
monitoring (MIHM) via FloTrac™ and EV1000™ in trauma patients.
Numerous factors are known to contribute to post-traumatic morbidity and mortality. Acute
blood loss, hypovolemia, and systemic inflammatory response syndrome can often develop
following severe traumatic injury and are, frequently, further exacerbated by the presence
of pre-existing health conditions. The culmination of these insults and/or pre-existing
conditions can precipitate an imbalance in oxygen delivery and consumption leading to tissue
ischemia and resultant organ dysfunction.
Tissue ischemia precipitates a disruption in the balance of oxygen delivery and consumption
often yielding a conversion from aerobic to anaerobic processes in order to maintain
metabolic functionality. The conversion to anaerobic processes leads to the production of
lactic acid and a resulting consumption of the body's basic buffers. Clinically, the
consumption of the body's basic buffers is frequently referred to as the development of a
base deficit. Both the production of lactic acid and the development of a base deficit have
been positively linked to the increased morbidity and mortality in multiple critically ill
patient populations, including those with traumatic injuries.
Multiple studies have linked the rate at which base deficit corrects or lactic acid clears
to the likelihood of survival. Accordingly, hemodynamic monitoring can provide vital
information concerning cardiovascular function including vascular volume, vascular
capacitance, and cardiac performance. Obtaining this information enables clinicians to
tailor interventions to target specific components of the cardiovascular system in order to
most effectively reverse the cause of tissue hypoxia, elevation in lactic acid, and base
deficit, while simultaneously decreasing the likelihood of causing harm through unnecessary
or unwarranted changes in management.
Advancements in hemodynamic monitoring technology now allow clinicians to obtain data by
using minimally invasive techniques. Devices utilizing this technology can be connected to
vascular access routinely utilized in the intensive care setting such as arterial lines.
These devices provide parameters such as systolic pressure variation (SPV), pulse pressure
variation (PPV) and stroke volume variation (SVV) to predict fluid responsiveness of
critically ill, mechanically ventilated patients. Studies evaluating these parameters have
shown them to have a 84-94% positive predictive value for fluid responsiveness. In addition,
higher variability in studied parameters were indicative of patients who were more likely to
be responsive to fluid challenges.
Modern clinical management in critically ill patients with cardiovascular dysfunction hinges
on reversal of the underlying cause of cardiovascular dysfunction. Recent management
strategies have used a multi-faceted approach in which multiple processes of potential
dysfunction can be monitored and managed simultaneously. Management is goal directed with
clearly defined endpoints for the management of vascular volume, cardiac performance as well
as maintenance of vascular capacitance. Hemodynamic monitoring technology is essential in
providing data that will allow clinical interventions to be tailored to patient-specific
physiology and provide goals for titration of therapy.
In recent years, data has emerged using goal directed therapy in the surgical patient
population with favorable outcomes suggesting a decrease in post-operative organ
dysfunction, ICU and hospital length of stay, however, there is limited data in the trauma
patient population. This study endeavors to determine if the implementation of
intra-operative monitoring will decrease the incidence of post-operative complications such
as acute lung injury, infections, thromboembolism, cerebral vascular accident, acute kidney
injury, myocardial infarction; in addition to the traditional outcome measures of mortality
and length of stay.
blood loss, hypovolemia, and systemic inflammatory response syndrome can often develop
following severe traumatic injury and are, frequently, further exacerbated by the presence
of pre-existing health conditions. The culmination of these insults and/or pre-existing
conditions can precipitate an imbalance in oxygen delivery and consumption leading to tissue
ischemia and resultant organ dysfunction.
Tissue ischemia precipitates a disruption in the balance of oxygen delivery and consumption
often yielding a conversion from aerobic to anaerobic processes in order to maintain
metabolic functionality. The conversion to anaerobic processes leads to the production of
lactic acid and a resulting consumption of the body's basic buffers. Clinically, the
consumption of the body's basic buffers is frequently referred to as the development of a
base deficit. Both the production of lactic acid and the development of a base deficit have
been positively linked to the increased morbidity and mortality in multiple critically ill
patient populations, including those with traumatic injuries.
Multiple studies have linked the rate at which base deficit corrects or lactic acid clears
to the likelihood of survival. Accordingly, hemodynamic monitoring can provide vital
information concerning cardiovascular function including vascular volume, vascular
capacitance, and cardiac performance. Obtaining this information enables clinicians to
tailor interventions to target specific components of the cardiovascular system in order to
most effectively reverse the cause of tissue hypoxia, elevation in lactic acid, and base
deficit, while simultaneously decreasing the likelihood of causing harm through unnecessary
or unwarranted changes in management.
Advancements in hemodynamic monitoring technology now allow clinicians to obtain data by
using minimally invasive techniques. Devices utilizing this technology can be connected to
vascular access routinely utilized in the intensive care setting such as arterial lines.
These devices provide parameters such as systolic pressure variation (SPV), pulse pressure
variation (PPV) and stroke volume variation (SVV) to predict fluid responsiveness of
critically ill, mechanically ventilated patients. Studies evaluating these parameters have
shown them to have a 84-94% positive predictive value for fluid responsiveness. In addition,
higher variability in studied parameters were indicative of patients who were more likely to
be responsive to fluid challenges.
Modern clinical management in critically ill patients with cardiovascular dysfunction hinges
on reversal of the underlying cause of cardiovascular dysfunction. Recent management
strategies have used a multi-faceted approach in which multiple processes of potential
dysfunction can be monitored and managed simultaneously. Management is goal directed with
clearly defined endpoints for the management of vascular volume, cardiac performance as well
as maintenance of vascular capacitance. Hemodynamic monitoring technology is essential in
providing data that will allow clinical interventions to be tailored to patient-specific
physiology and provide goals for titration of therapy.
In recent years, data has emerged using goal directed therapy in the surgical patient
population with favorable outcomes suggesting a decrease in post-operative organ
dysfunction, ICU and hospital length of stay, however, there is limited data in the trauma
patient population. This study endeavors to determine if the implementation of
intra-operative monitoring will decrease the incidence of post-operative complications such
as acute lung injury, infections, thromboembolism, cerebral vascular accident, acute kidney
injury, myocardial infarction; in addition to the traditional outcome measures of mortality
and length of stay.
Inclusion Criteria:
1. 18 years of age or older
2. Injury Severity Score > 15 (indicator of anticipated trauma mortality)
3. Admission to Surgical-Trauma ICU (STICU)
4. Anticipated surgery within 72 hours of admission
5. American Society of Anesthesiology patient classification status (ASA) 2-5
6. Lactic acid > 2.5 within 24 hours of surgical procedure or Base deficit ≥ - 5 mmol/L,
or persistent requirement for vasopressor support within 24 hours of surgical
procedure
7. Patient requires mechanical ventilation prior to consenting surgery
8. Vascular devices that include a minimum of an arterial line
9. Minimally invasive hemodynamic monitoring initiated prior to first surgical procedure
unless patient is taken emergently, e.g. OR from trauma bay
10. Patients requiring emergent initial operative procedures will be eligible for
consenting if above criteria are met prior to their second surgical procedure
11. Anticipated operative procedure precipitating evaluation and/or consenting for study
must be > 30 minutes in duration
- Procedures < 30 minutes would not result in significant metabolic stress
necessitating a continuation of MIHM
Exclusion Criteria:
1. Pregnancy
2. Exclusions due to limitations with respect to accuracy of MIHM:
- Patients not intubated prior to surgical procedure
- Patients requiring an open thoracotomy
- Patients with known history of surgical intervention for peripheral vascular
disease
- Patients with pre-existing atrial arrhythmias
- Patients who are on cardiopulmonary bypass
3. Isolated acute cerebral injury and/or traumatic cerebral injury
- Hemodynamic management in this patient population does not always follow
typical/standard endpoints due to nuances of managing intracranial pressures
4. Cardiac arrest prior to enrollment
5. Patients with pre-existing, dialysis dependent, renal failure upon admission
- Hemodynamic management in this patient population does not always follow
typical/standard endpoints due to nuances of managing renal failure
6. Patients with pre-existing cirrhosis
- Hepatic failure results in abnormal clearance of lactic acid
7. Patients with no survival injuries, e.g. gunshot wound to the head
We found this trial at
1
site
Charleston, West Virginia 25301
Principal Investigator: Audis Bethea, PharmD, BCPS
Phone: 304-388-6260
Click here to add this to my saved trials